Table 11.
Management of behavioral disturbances in PSP/CBS.
1. Pharmacologic management |
a. Apathy: |
i. Trial of modafinil or methylphenidate |
b. Impulsivity |
i. Behavioral approaches difficult because of frontal deficit. |
ii. Reduce levodopa and other dopaminergic medications |
iii. Trial of SSRI such as escitalopram or sertraline at standard dosages |
iv. Mood stabilizers such as valproic acid and lamotrigine |
v. ADHD drugs such as atomoxetine |
c. Depression/Mood disorder |
i Trial of SSRI at standard dosages |
ii Avoid tricyclic antidepressants due to side effects |
d. Pseudobulbar affect |
i. Trial of SSRI at standard dosages |
ii. Dextromethorphan-quinidine (second-line due to cost) |
2. Non-pharmacologic management |
a. Caregiver/family education emphasizing that deficit is part of disease |
b. Occupational therapy |
c. Cognitive behavioral therapy |
d. Safety screening |
i. Risk of medication mismanagement, |
ii. Financial risk |
iii. Use of a stove |
iv. Driving |
v. Exposure to unsecured firearms |